As filed with the Securities and Exchange Commission on February 11, 2008
Registration No. 333-148432
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
APPLICATION FOR WITHDRAWAL
OF
REGISTRATION STATEMENT
(FILE NO. 333-148432)
HUMAN BIOSYSTEMS
(Exact Name of Small Business Issuer in its Charter)
CALIFORNIA 8731
(State or Jurisdiction of (Primary Standard Industrial
Incorporation or Organization) Classification Code Number)
77-0481056
(I.R.S. Employer Identification Number)
1127 Harker Avenue
Palo Alto, California 94301
(650) 323-0943
(Address and Telephone Number
of Principal Executive Offices and
Principal Place of Business)
Mr. Harry Masuda
Chief Executive Officer
Human BioSystems
1127 Harker Avenue
Palo Alto, California 94301
(650) 323-0943
(Name, Address and Telephone Number,
of Agent for Service)
Copy to:
Cathryn S. Gawne, Esq.
Hopkins & Carley
70 South First Street
San Jose, California 95113
(408) 286-9800
(408) 938-6281 (telecopier)
=============================================================================================================================================================================
February 11, 2008
VIA EDGAR
Securities and Exchange Commission
100 F Street, NE,
Washington, D.C. 20549-1090
Attn: Mr. Jeffrey Riedler
Assistant Director
Mail Stop 6010
Re: Human BioSystems
Registration Statement on Form SB-2
Filed January 2, 2008
File No. 333-148432
Client-Matter No. 24015.002
Dear Mr. Riedler:
Pursuant to Rules 477 and 478 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned authorized officer of Human BioSystems, a California corporation (the “Company”), hereby requests that the Registration Statement on Form SB-2, including all exhibits thereto (Registration No. 333-148432) (the “Registration Statement”), relating to the Company’s common stock, no par value (the “Common Stock”), be withdrawn, effective immediately. The Registration Statement has not been declared effective, and no offers or sales have been made or will be made under the Registration Statement.
The Company acknowledges that no refund will be made for fees paid to the Commission in connection with filing of the Registration Statement. However, the Company requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use should the Company proceed with the filing of a subsequent registration statement meeting the requirements of Rule 457(p) under the Securities Act.
If you have any questions regarding this application for withdrawal, please contact Cathryn S. Gawne, legal counsel to the Company, at (408) 286-9800.
HUMAN BIOSYSTEMS | ||
By: |
| /s/ Harry Masuda |
| Harry Masuda | |
| Chief Executive Officer |